ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 93 filers reported holding ANAVEX LIFE SCIENCES CORP in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,447 | -1.6% | 4,343 | +22.1% | 0.00% | 0.0% |
| Q2 2023 | $28,918 | -5.1% | 3,557 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $30,483 | -20.8% | 3,557 | -14.4% | 0.00% | 0.0% |
| Q4 2022 | $38,475 | -10.3% | 4,155 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $42,880 | +3.1% | 4,155 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $41,592 | -18.7% | 4,155 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $51,148 | -83.4% | 4,155 | -76.6% | 0.00% | -50.0% |
| Q4 2021 | $308,271 | -3.4% | 17,778 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $319,115 | -21.5% | 17,778 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $406,405 | +68.0% | 17,778 | +9.8% | 0.01% | +50.0% |
| Q1 2021 | $241,966 | +691.4% | 16,185 | +185.9% | 0.00% | – |
| Q4 2020 | $30,575 | +96.8% | 5,662 | +65.8% | 0.00% | – |
| Q3 2020 | $15,538 | -82.2% | 3,415 | -80.8% | 0.00% | -100.0% |
| Q2 2020 | $87,502 | – | 17,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 942,500 | $9,727,000 | 3.29% |
| Pier Capital, LLC | 384,811 | $3,971,000 | 0.68% |
| AllSquare Wealth Management LLC | 65,956 | $681,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $1,032,000 | 0.35% |
| Royal Capital Wealth Management, LLC | 18,500 | $191,000 | 0.22% |
| Bridgefront Capital, LLC | 10,214 | $105,000 | 0.11% |
| Hikari Power Ltd | 85,585 | $883,000 | 0.10% |
| Orion Capital Management LLC | 9,500 | $98,000 | 0.08% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,158 | $889,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 66,459 | $686,000 | 0.04% |